Viridian Therapeutics, Inc. (VRDN)

32.43 -0.83 (-2.50%) USD  |  NASDAQ  |  Jan 20, 12:11
More

Viridian Therapeutics Net Non-Operating Interest Income Expense (Quarterly)

Net Non-Operating Interest Income Expense (Quarterly) Chart

View Net Non-Operating Interest Income Expense (Quarterly) for VRDN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Non-Operating Interest Income Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks
Start Trial
Marker Therapeutics, Inc. Upgrade
Orthofix Medical, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Avantor, Inc. Upgrade
Immunovant, Inc. Upgrade